Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients

BACKGROUND: A substantial proportion of critically ill COVID-19 patients develop thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis are associated with lower mortality rates. The purpose of the study was to evaluate the association between initial dosing strat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Crit Care
Main Authors: Jonmarker, Sandra, Hollenberg, Jacob, Dahlberg, Martin, Stackelberg, Otto, Litorell, Jacob, Everhov, Åsa H., Järnbert-Pettersson, Hans, Söderberg, Mårten, Grip, Jonathan, Schandl, Anna, Günther, Mattias, Cronhjort, Maria
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7680989/
https://ncbi.nlm.nih.gov/pubmed/33225952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03375-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki